REKVINA LABS | O P CHAINS | REKVINA LABS/ O P CHAINS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -180.8 | -192.7 | - | View Chart |
P/BV | x | 6.7 | 0.7 | 972.4% | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
REKVINA LABS O P CHAINS |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
REKVINA LABS Mar-18 |
O P CHAINS Mar-23 |
REKVINA LABS/ O P CHAINS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 6 | 22 | 25.6% | |
Low | Rs | 5 | 11 | 44.4% | |
Sales per share (Unadj.) | Rs | 0 | 2.2 | 0.0% | |
Earnings per share (Unadj.) | Rs | -0.1 | 3.4 | -3.9% | |
Cash flow per share (Unadj.) | Rs | -0.1 | 3.4 | -3.9% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 0.7 | 47.5 | 1.4% | |
Shares outstanding (eoy) | m | 6.03 | 6.85 | 88.0% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0 | 7.6 | - | |
Avg P/E ratio | x | -39.9 | 4.9 | -816.9% | |
P/CF ratio (eoy) | x | -39.9 | 4.9 | -816.9% | |
Price / Book Value ratio | x | 7.8 | 0.3 | 2,261.5% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 32 | 113 | 28.2% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 0 | 1 | 0.0% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 0 | 15 | 0.0% | |
Other income | Rs m | 0 | 24 | 0.8% | |
Total revenues | Rs m | 0 | 39 | 0.5% | |
Gross profit | Rs m | -1 | -1 | 135.6% | |
Depreciation | Rs m | 0 | 0 | - | |
Interest | Rs m | 0 | 0 | - | |
Profit before tax | Rs m | -1 | 23 | -3.4% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 0 | 0 | 0.0% | |
Profit after tax | Rs m | -1 | 23 | -3.5% | |
Gross profit margin | % | 0 | -4.9 | - | |
Effective tax rate | % | 0 | 0.7 | -0.0% | |
Net profit margin | % | 0 | 155.3 | - |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 6 | 137 | 4.1% | |
Current liabilities | Rs m | 4 | 0 | 1,800.0% | |
Net working cap to sales | % | 0 | 920.9 | - | |
Current ratio | x | 1.4 | 623.5 | 0.2% | |
Inventory Days | Days | 0 | 4,618 | - | |
Debtors Days | Days | 0 | 0 | - | |
Net fixed assets | Rs m | 2 | 188 | 1.2% | |
Share capital | Rs m | 30 | 69 | 44.0% | |
"Free" reserves | Rs m | -26 | 257 | -10.2% | |
Net worth | Rs m | 4 | 325 | 1.2% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 8 | 325 | 2.5% | |
Interest coverage | x | 0 | 0 | - | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0 | 0 | 0.0% | |
Return on assets | % | -10.0 | 7.1 | -140.4% | |
Return on equity | % | -19.7 | 7.1 | -277.0% | |
Return on capital | % | -19.6 | 7.2 | -274.7% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 0 | - | |
Fx outflow | Rs m | 0 | 0 | - | |
Net fx | Rs m | 0 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 0 | -82 | 0.3% | |
From Investments | Rs m | NA | 82 | 0.0% | |
From Financial Activity | Rs m | NA | NA | - | |
Net Cashflow | Rs m | 0 | 0 | -59.1% |
Indian Promoters | % | 45.1 | 74.5 | 60.5% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 0.0 | - | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 54.9 | 25.5 | 215.6% | |
Shareholders | 2,226 | 46 | 4,839.1% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare REKVINA LABS With: ADANI ENTERPRISES REDINGTON MMTC NOVARTIS SIRCA PAINTS INDIA
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | REKVINA LABS | O P CHAINS | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.00% | 0.00% | 0.11% |
1-Month | 0.00% | 0.00% | 2.53% |
1-Year | 7.91% | 30.56% | 53.46% |
3-Year CAGR | -3.77% | 43.70% | 13.74% |
5-Year CAGR | -8.27% | 24.30% | 21.84% |
* Compound Annual Growth Rate
Here are more details on the REKVINA LABS share price and the O P CHAINS share price.
Moving on to shareholding structures...
The promoters of REKVINA LABS hold a 45.1% stake in the company. In case of O P CHAINS the stake stands at 74.5%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of REKVINA LABS and the shareholding pattern of O P CHAINS.
Finally, a word on dividends...
In the most recent financial year, REKVINA LABS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.
O P CHAINS paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of REKVINA LABS, and the dividend history of O P CHAINS.
For a sector overview, read our pharmaceuticals sector report.
After opening the day marginally higher, Indian share markets reversed the trend as the session progressed and ended the day lower.